HLB Therapeutics Market Cap

HLB Therapeutics has a market cap or net worth of 345.15 billion as of July 11, 2025. Its market cap has decreased by -40.01% in one year.

Market Cap

345.15B

Enterprise Value

374.26B

Revenue

57.22B

Ranking

n/a

PE Ratio

n/a

Stock Price

4,090.00

Market Cap Chart

Since March 26, 2010, HLB Therapeutics's market cap has increased from 105.80B to 345.15B, an increase of 226.21%. That is a compound annual growth rate of 8.03%.

Market Cap History

Date	Market Cap	% Change
Jul 11, 2025	345.15B	-63.07%
Dec 30, 2024	934.49B	182.02%
Dec 28, 2023	331.36B	-9.25%
Dec 29, 2022	365.14B	-3.64%
Dec 30, 2021	378.91B	-51.22%
Dec 30, 2020	776.71B	0.46%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	75.23T
Celltrion	39.45T
ALTEOGEN	23.46T
Yuhan	8,355.28B
SK Biopharmaceuticals	7,698.19B
HLB Co., Ltd.	6,716.00B
PharmaResearch	5,828.59B
LigaChem Biosciences	4,955.66B

Market Cap Rankings